Our Innovations

Boréaceutique is a biotechnology company primarily engaged in developing active ingredients derived from plants native to the boreal forest. ECOGENE-21 has been working closely with this innovative company for several years, particularly in supporting the valorization of its innovations and transition to clinical application.

Protection and valorization of medical and biotechnological innovations resulting from our research.

ECOGENE-21 collaborates with EDER Therapeutics, a Canadian company whose mission is to provide innovative treatments and healthcare services to Canadian patients with rare diseases, supporting both development and commercialization.

A suite of interactive lipidology tools including an educational game, explanatory videos, and a book to better understand dyslipidemias.

An international platform for sharing knowledge about rare and severe dyslipidaemias, bringing together researchers, clinicians, patients and family carers.

An intelligent clinical data management platform designed to facilitate the integration of health data and optimize clinical trials.

A family of smart containers specialized in the transport (including by drone) of medications, biological samples, and fragile therapeutic vectors for gene therapy.

Development of genetic tests to identify carriers of genetic diseases, thus enabling prevention and personalized care.